Literature DB >> 15640003

[Association of 7alpha-hydroxylase gene polymorphism with levels of plasma lipids].

Bin Zhou1, Si-Zhong Zhang, Cui-Ying Xiao, Ke-Lan Zhang, Li Zhang, Gui-Xing Li, Ping Li, He-Kun Liu, Ke-Qin Zheng.   

Abstract

To study the distribution of Eco31I restriction polymorphism in nucleotide -204 of 7alpha-hydroxylase gene(CYP7A1)in Sichuan Han population of China and association of the polymorphism with coronary heart disease(CHD),CYP7A1 genotyping was performed by using PCR-RFLP approach in 183 CHD patients and 101 control subjects. 7alpha-hydroxylase gene allele frequencies of C,A were 0.840 and 0.160 in CHD group and 0.822 and 0.178 in control group,respectively. There was no significant difference in frequencies of allele and genotypes in A-204C polymorphism between CHD group and control group (P>0.05). However, in CHD patients there was significant difference in total cholesterol (TC) levels among CC,CA and AA genotypes (P<0.05) ,and the levels of high density lipoprotein cholesterol (HDL-C) and low density lipoprotein cholesterol (LDL-C) in CHD patients with AA genotype were lower than those in CHD patients with CC and CA genotypes(P<0.05). In control group there was significant difference in TC levels between CC and CA genotypes (P<0.05) . The frequencies of C,A alleles at A-204C polymorphic site were significantly different from those reported in white people(P<0.05). The results indicating that no direct association was found between the A-204C polymorphism and CHD,but there was significant correlation between this polymorphism and the levels of TC ,and there was significant correlation in CHD patient group between this polymorphism and levels of HDL-C and LDL-C.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15640003

Source DB:  PubMed          Journal:  Yi Chuan        ISSN: 0253-9772


  3 in total

Review 1.  Role of cholesterol 7alpha-hydroxylase (CYP7A1) in nutrigenetics and pharmacogenetics of cholesterol lowering.

Authors:  Jaroslav A Hubacek; Dagmar Bobkova
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

2.  Linkage disequilibrium blocks, haplotype structure, and htSNPs of human CYP7A1 gene.

Authors:  Kaori Nakamoto; Shuang Wang; Robert D Jenison; Grace L Guo; Curtis D Klaassen; Yu-Jui Yvonne Wan; Xiao-bo Zhong
Journal:  BMC Genet       Date:  2006-05-18       Impact factor: 2.797

3.  Relationship between CYP7A1 -204A>C polymorphism with gallbladder stone disease and serum lipid levels: a meta-analysis.

Authors:  Qiang Cai; Zhen-Qiang Wang; Qu Cai; Chen Li; Er-Zhen Chen; Zhao-Yan Jiang
Journal:  Lipids Health Dis       Date:  2014-08-08       Impact factor: 3.876

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.